Börner P, Deicher H, Bähr I, Chelius H H, Ghani G, Geldmacher H, Henke I W, Kindermann L, Marks V
Dtsch Med Wochenschr. 1977 May 20;102(20):745-51. doi: 10.1055/s-0028-1104964.
During 1971 and 1972 1109 rh-negative mothers with an Rh-positive child were treated with an intravenous standard dose of 80-120 microng of IgG anti-D. To achieve complete elimination of fetal erythrocytes within 72 hours after the first immunoglobulin injection this standard dose had to be increased in 14% of the women. In 1973 and 1974 1138 rh-negative mothers of Rh-positive children were treated with an intravenous standard dose of 240 microng of IgG anti-D. This dose was insufficient in only 1.2% of the rh-negative mothers. More than 98.8% of all women are protected by a standard intravenous dose of 240 microng of IgG anti-D and a single erythrocyte elimination control 72 hours after the birth. It appears that the results after intravenous immunoglobulin are as a whole significantly better than after intramuscular IgG anti-D.
在1971年至1972年期间,1109名Rh阴性母亲所生的Rh阳性孩子接受了静脉注射标准剂量80 - 120微克IgG抗D治疗。为了在首次注射免疫球蛋白后72小时内完全清除胎儿红细胞,14%的女性需要增加标准剂量。1973年至1974年,1138名Rh阳性孩子的Rh阴性母亲接受了静脉注射标准剂量240微克IgG抗D治疗。该剂量仅在1.2%的Rh阴性母亲中不足。超过98.8%的女性通过静脉注射240微克IgG抗D的标准剂量以及出生后72小时进行的单次红细胞清除控制得到了保护。静脉注射免疫球蛋白后的整体效果似乎明显优于肌肉注射IgG抗D后的效果。